Investing
1067 Articles
courtesy of VerizonThe short interest data for the end of November is out, and the results are somewhat surprising when it…
ThinkstockThere is a trend at the end of each year followed by many income investors. This is the Dogs of…
ThinkstockInvestors love dividends, particularly safe and dependable dividends that rise through time. The S&P 500 Index currently has the most…
ThinkstockThe market for pharmaceuticals and biotech drugs just keeps growing. The so-called patent cliff may be affecting Big Pharma companies…
ThinkstockSkin cancer treatments remain elusive. While some drugs are on the market for advanced-stage treatment, the most common and longest…
While the past two years were all about getting the house back in order, the UBS equity strategy team thinks…
Jon OggWe have now seen the short interest reports from the October 31 settlement date and have compared them to…
ThinkstockThe unemployment situation in the United States looked relatively good through the first half of the year. The jobless rate…
ThinkstockOctober’s jobs report showed a gain of 204,000 people to nonfarm payrolls. That is a pace of 1.5 million job additions…
Jon OggInvestors are having to deal with seeing stocks hit new highs almost daily now. With a temporary deal in…
The drug patent cliff for Big Pharma is coming with some continued consequences, and two drug giants with earnings this…
ThinkstockDrug giant Merck & Co. Inc. (NYSE: MRK) reported third-quarter 2013 results before markets opened Monday morning. The company posted…
courtesy of Verizon WirelessMergers and acquisitions (M&A) sometimes can be an excellent measure of the economy’s financial health. However, since…
Jon OggEarnings season is in full swing and this coming week will bring many key earnings reports. This will also…
Jon OggWe have seen the short interest reports for the October 15 settlement date. It turns out that short sellers…
Our top personal finance-related articles today. Your wallet will thank you later.